European Union · Question · QUESTION_WRITTEN
E-9-2024-001319
Impact of PFAS restrictions on the availability of medicinal products and medical devices
Introduced
25 April 2024
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
3 July 2024
Records
Official question E-9-2024-001319 from European Union at European Parliament. Dated 25 April 2024. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
Impact of PFAS restrictions on the availability of medicinal products and medical devices
Impact of PFAS restrictions on the availability of medicinal products and medical devices
QUESTION_WRITTEN · EN · 6 May 2024
Impact of PFAS restrictions on the availability of medicinal products and medical devices
QUESTION_WRITTEN · EN · 6 May 2024
Answer
QUESTION_WRITTEN_ANSWER · 3 July 2024
Virkningen af PFAS‑begrænsninger på tilgængeligheden af lægemidler og medicinsk udstyr
QUESTION_WRITTEN · DA · 6 May 2024
Virkningen af PFAS‑begrænsninger på tilgængeligheden af lægemidler og medicinsk udstyr
QUESTION_WRITTEN · DA · 6 May 2024
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.